Sickle-Cell Patients See Hope in CRISPR – MIT Technology Review
MIT Technology Review |
Sickle-Cell Patients See Hope in CRISPR
MIT Technology Review The idea is that CRISPR could correct the genetic mutation responsible for sickle-cell so that patients' bodies could make normal red blood cells, alleviating the pain and other severe symptoms associated with the disease. Researchers have already … |
